Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Bay X 1005

Known as: Bay X1005, BAYX-1005, Bay-X1005 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2009
Review
2009
Leukotrienes are lipid inflammatory mediators that are implicated in asthma, COPD, arthritis, cardiovascular disease and cancer… Expand
Is this relevant?
2007
2007
Methods: Investigators conducted a prospective, randomized, placebo-controlled, crossover trial of the leukotriene antagonist (DG… Expand
Is this relevant?
Highly Cited
2005
Highly Cited
2005
CONTEXT Myocardial infarction (MI) is the leading cause of death in the world. Variants in the 5-lipoxygenase-activating protein… Expand
Is this relevant?
Highly Cited
2005
Highly Cited
2005
ContextMyocardial infarction (MI) is the leading cause of death in the world. Variants in the 5-lipoxygenase–activating protein… Expand
Is this relevant?
2005
2005
BACKGROUND MMP-13 is one of the most important metalloproteases (MMP) involved in osteoarthritis. Licofelone, a novel dual… Expand
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2002
Highly Cited
2002
OBJECTIVE To compare the effect of licofelone, NS-398 (an inhibitor of cyclooxygenase 2 [COX-2]), and BayX-1005 (an inhibitor of… Expand
Is this relevant?
Review
1997
Review
1997
This article reviews the literature on the effects of leukotrienes in asthma. In particular, the ability of recently developed… Expand
Is this relevant?